Skip to main content

ADVERTISEMENT

cilostazol

Original Contribution
02/28/2017

Maria Fernanda Zuliani Mauro, MD1;  J. Armando Mangione, MD1;  J. Ribamar Costa, Jr, MD2;  Ricardo Costa, MD2;  Luiz Alberto Piva e Mattos, MD2;  Rodolfo Staico, MD2;  Fausto Feres, MD2;  Dimytri Siqueira, MD2;  Amanda Sousa, MD2;  Alexandre Abizaid, MD2

Maria Fernanda Zuliani Mauro, MD1;  J...
This prospective, placebo-controlled trial was conducted in diabetic patients randomized (1:1) to receive either standard DAPT vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent.
This prospective, placebo-controlled trial was conducted in diabetic patients randomized (1:1) to receive either standard DAPT vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent.
This prospective,...
02/28/2017
Journal of Invasive Cardiology